Brief: Landos Biopharma Q3 Net Income USD -5.86 Million
09/11/2023 13:00
Nov 09 (Reuters) - Landos Biopharma Q3 operating expenses USD 5.199 million. * Q3 basic EPS USD -0.94 * Q3 operating income USD -5.199 million
Recent news on Landos Biopharma
See all newsLandos Biopharma Inc expected to post a loss of 100 cents a share - Earnings Preview
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Super Micro, Micron Technology, Navios Maritime
U.S. STOCKS ON THE MOVE-Landos Biopharma, Foot Locker, US energy sector
Brief: AbbVie To Acquire Landos Biopharma